Background pattern
VIZARSIN 100 mg FILM-COATED TABLETS

VIZARSIN 100 mg FILM-COATED TABLETS

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use VIZARSIN 100 mg FILM-COATED TABLETS

Introduction

Package Leaflet: Information for the User

Vizarsin 100 mg Film-Coated Tablets

sildenafil

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack and other information

  1. What is Vizarsin and what is it used for
  2. What you need to know before you take Vizarsin
  3. How to take Vizarsin
  4. Possible side effects
  5. Storing Vizarsin
  6. Contents of the pack and other information

1. What is Vizarsin and what is it used for

Vizarsin contains the active substance sildenafil, which belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors. It works by dilating the blood vessels in the penis, allowing blood to flow in when you are sexually stimulated. Vizarsin will only help you to get an erection if you are sexually stimulated.

Vizarsin is indicated for the treatment of erectile dysfunction in adult men, sometimes referred to as impotence. This occurs when a man cannot get or maintain an erection that is sufficient for satisfactory sexual activity.

2. What you need to know before you take Vizarsin

Do not take Vizarsin

  • If you are allergic to sildenafil or any of the other ingredients of this medicine (listed in section 6).
  • If you are taking medicines called nitrates, as the combination may lead to a dangerous decrease in your blood pressure. Consult your doctor if you are taking any of these medicines, often used to relieve angina pectoris (or "chest pain"). If you are unsure, consult your doctor or pharmacist.
  • If you are using any of the medicines called nitric oxide donors, such as amyl nitrate ("poppers"), as the combination may lead to a dangerous decrease in your blood pressure.
  • If you are taking riociguat. This medicine is used to treat pulmonary arterial hypertension (i.e., high blood pressure in the lungs) and chronic thromboembolic pulmonary hypertension (i.e., high blood pressure in the lungs caused by blood clots). PDE5 inhibitors, such as Vizarsin, have shown that they increase the hypotensive effect of this medicine. If you are taking riociguat or are unsure, consult your doctor.
  • If you have a severe heart or liver problem.
  • If you have recently had a stroke or heart attack or if you have low blood pressure.
  • If you have a rare inherited eye disease (such as retinitis pigmentosa).
  • If you have previously experienced a loss of vision due to non-arteritic anterior ischemic optic neuropathy (NAION).

Warnings and precautions

Consult your doctor or pharmacist before taking Vizarsin:

  • If you have sickle cell anemia (a disorder of the red blood cells), leukemia (cancer of the blood cells), or multiple myeloma (cancer of the bone marrow).
  • If you have a penis deformity or Peyronie's disease.
  • If you have heart problems. Your doctor should carefully check if your heart can withstand the extra strain of having sex.
  • If you have current stomach ulcers or bleeding problems (such as hemophilia).
  • If you experience a sudden decrease or loss of vision, stop taking Vizarsin and contact your doctor immediately.

It is not recommended to use Vizarsin in combination with any other oral or local treatment for erectile dysfunction.

You must not take Vizarsin with treatments for pulmonary arterial hypertension (PAH) that contain sildenafil or any other PDE5 inhibitor.

You must not take Vizarsin if you do not have erectile dysfunction.

The use of Vizarsin is not indicated in women.

Special considerations in patients with kidney or liver problems

You should inform your doctor if you have kidney or liver problems. Your doctor may decide to reduce your dose.

Children and adolescents

The use of Vizarsin is not indicated in persons under 18 years of age.

Using Vizarsin with other medicines

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

Vizarsin tablets may interfere with some medicines, especially those used to treat chest pain. In the event of a medical emergency, you should inform your doctor, pharmacist, or nurse that you are taking Vizarsin and when you took it. Do not take Vizarsin with other medicines unless your doctor advises you to.

You must not take Vizarsin if you are taking medicines called nitrates, as the combination may lead to a dangerous decrease in your blood pressure. Always inform your doctor, pharmacist, or nurse if you are taking any of these medicines, often used to relieve angina pectoris (or "chest pain").

You must not take Vizarsin if you are taking medicines called nitric oxide donors, such as amyl nitrate ("poppers"), as the combination may also lead to a dangerous decrease in your blood pressure. Inform your doctor or pharmacist if you are taking riociguat.

If you are taking medicines known as protease inhibitors, such as those used to treat HIV, your doctor may recommend that you start with the lowest dose (25 mg) of Vizarsin.

Some patients who are taking an alpha-blocker, a medicine used to treat high blood pressure or an enlarged prostate, may experience dizziness or lightheadedness that can be caused by a decrease in blood pressure when sitting or standing up quickly. Some patients have experienced these symptoms when taking Vizarsin with alpha-blockers. This is more likely to happen within 4 hours after taking Vizarsin. To minimize the likelihood of these symptoms, you should be taking your daily dose of the alpha-blocker regularly before starting Vizarsin. Your doctor may advise you to start with the lower dose (25 mg) of Vizarsin.

Using Vizarsin with food, drinks, and alcohol

Vizarsin can be taken with or without food. However, you may notice that Vizarsin takes a little longer to work if you take it with a large meal.

Consuming alcohol may temporarily impair your ability to get an erection. Therefore, to get the maximum benefit from the medicine, it is advised not to drink large amounts of alcohol before taking Vizarsin.

Pregnancy, breastfeeding, and fertility

The use of Vizarsin is not indicated in women.

Driving and using machines

Vizarsin can cause dizziness and affect vision. You should know how you react to Vizarsin before driving or operating machinery.

Vizarsin contains lactose and sodium

If your doctor has told you that you have an intolerance to some sugars, consult him before taking this medicine.

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".

3. How to take Vizarsin

Always take this medicine exactly as your doctor or pharmacist has told you. If you are unsure, consult your doctor or pharmacist.

The recommended starting dose is 50 mg.

You must not take Vizarsin more than once a day.

You should take Vizarsin about one hour before you plan to have sex. Swallow the tablet whole with a glass of water.

If you notice that the effect of Vizarsin is too strong or too weak, tell your doctor or pharmacist.

Vizarsin will only help you to get an erection if you are sexually stimulated. The time Vizarsin takes to work varies from person to person, but it normally takes between 30 minutes and 1 hour. The effect of Vizarsin may be delayed if you take it with a large meal.

If Vizarsin does not help you to get an erection, or if the erection does not last long enough to complete sexual intercourse, consult your doctor.

If you take more Vizarsin than you should

You may experience an increase in side effects and their severity. Doses above 100 mg do not increase efficacy.

You must not take more tablets than your doctor prescribes.

Contact your doctor if you have taken more tablets than you should.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. The side effects reported with Vizarsin are usually mild to moderate and short-lived.

If you experience any of the following serious side effects, stop taking Vizarsin and seek medical attention immediately:

  • Allergic reaction - this occurs rarely(may affect up to 1 in 100 people).

Symptoms include sudden wheezing, difficulty breathing or dizziness, swelling of the eyelids, face, lips or throat.

  • Chest pain - this occurs rarely.

If this occurs during or after intercourse:

  • Sit in a semi-upright position and try to relax.
  • Do not use nitratesto treat chest pain.
  • Prolonged and sometimes painful erections - this occurs rarely(may affect up to 1 in 1,000 people).

If you have an erection that lasts more than 4 hours, you should contact your doctor immediately.

  • Sudden decrease or loss of vision - this occurs rarely.
  • Severe skin reactions - this occurs rarely.

Symptoms can include severe skin peeling and swelling, blistering of the mouth, genitals, and around the eyes, as well as fever.

  • Seizures or fits - this occurs rarely.

Other side effects:

Very common(may affect more than 1 in 10 people): headache.

Common(may affect up to 1 in 10 people): nausea, facial flushing, hot flush (including a feeling of warmth), indigestion, abnormal color perception, blurred vision, visual disturbance, nasal congestion, and dizziness.

Uncommon(may affect up to 1 in 100 people): vomiting, skin rash, eye irritation, eye discharge/red eyes, eye pain, seeing flashes of light, increased sensitivity to light, watery eyes, palpitations, rapid heartbeat, high blood pressure, low blood pressure, muscle pain, feeling sleepy, reduced sense of touch, vertigo, ringing in the ears, dry mouth, blocked or stuffy nose (including symptoms such as runny nose, sneezing, and nasal congestion), abdominal pain, gastroesophageal reflux disease (including symptoms such as heartburn), blood in urine, pain in arms or legs, nosebleeds, feeling hot, and feeling tired.

Rare(may affect up to 1 in 1,000 people): fainting, stroke, heart attack, irregular heartbeat, temporary decrease in blood flow to parts of the brain, feeling of pressure in the throat, numbness in the mouth, bleeding in the back of the eye, double vision, decreased sharpness of vision, abnormal sensation in the eye, eye swelling or eyelid swelling, small particles or spots in the vision, seeing halos around lights, dilation of the pupil, change in color of the white of the eye, bleeding from the penis, presence of blood in the semen, dry nose, swelling inside the nose, feeling irritable, and sudden decrease or loss of hearing.

During post-marketing experience, unstable angina (heart disease) and sudden death have been reported rarely. It should be noted that most men who experienced these side effects had pre-existing heart disease before taking this medicine. It is not possible to determine whether these side effects were directly related to Vizarsin.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing Vizarsin

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Package Contents and Additional Information

Vizarsin Composition

  • The active ingredient is sildenafil. Each film-coated tablet contains sildenafil citrate equivalent to 100 mg of sildenafil.
  • The other ingredients are:

Tablet core:

microcrystalline cellulose (E460), hydrogenated calcium phosphate, sodium croscarmellose, hypromellose (E464), magnesium stearate (E470b).

Film coating:

film coating: lactose monohydrate, hypromellose (E464), titanium dioxide (E171), triacetin (E1518).

See section 2 "Vizarsin contains lactose and sodium".

Product Appearance and Package Contents

Vizarsin 100 mg film-coated tablets are white, oblong, and engraved with "100" on one side.

Vizarsin 100 mg film-coated tablets are available in packs of 1 film-coated tablet in a blister pack and also in packs of 4 x 1, 8 x 1, or 12 x 1 film-coated tablet in perforated unit dose blisters.

Only some pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia

For further information on this medicinal product, please contact the local representative of the Marketing Authorisation Holder:

België/Belgique/Belgien

KRKA Belgium, SA.

Tél/Tel: + 32 (0) 487 50 73 62

Lietuva

UAB KRKA Lietuva

Tel: + 370 5 236 27 40

Text in Bulgarian language with contact information of a pharmaceutical company in Bulgaria including phone number

Luxembourg/Luxemburg

KRKA Belgium, SA.

Tél/Tel: + 32 (0) 487 50 73 62 (BE)

Ceská republika

KRKA CR, s.r.o.

Tel: + 420 (0) 221 115 150

Magyarország

KRKA Magyarország Kereskedelmi Kft.

Tel.: + 36 (1) 355 8490

Danmark

KRKA Sverige AB

Tlf: + 46 (0)8 643 67 66 (SE)

Malta

  • J. Busuttil Ltd.

Tel: + 356 21 445 885

Deutschland

TAD Pharma GmbH

Tel: + 49 (0) 4721 606-0

Nederland

KRKA Belgium, SA.

Tel: + 32 (0) 487 50 73 62 (BE)

Eesti

KRKA, d.d., Novo mesto Eesti filiaal

Tel: + 372 (0) 6 671 658

Norge

KRKA Sverige AB

Tlf: + 46 (0)8 643 67 66 (SE)

Ελλáδα

KRKA ΕΛΛΑΣ ΕΠΕ

Τηλ: + 30 2100101613

Österreich

KRKA Pharma GmbH, Wien

Tel: + 43 (0)1 66 24 300

España

KERN PHARMA, S.L.

Tel: + 34 93 700 25 25

Polska

KRKA-POLSKA Sp. z o.o.

Tel.: + 48 (0)22 573 7500

France

KRKA France Eurl

Tél: + 33 (0)1 57 40 82 25

Portugal

KRKA Farmacêutica, Sociedade Unipessoal Lda.

Tel: + 351 (0)21 46 43 650

Hrvatska

KRKA - FARMA d.o.o.

Tel: + 385 1 6312 100

România

KRKA Romania S.R.L., Bucharest

Tel: + 4 021 310 66 05

Ireland

KRKA Pharma Dublin, Ltd.

Tel: + 353 1 413 3710

Slovenija

KRKA, d.d., Novo mesto

Tel: + 386 (0) 1 47 51 100

Ísland

LYFIS ehf.

Sími: + 354 534 3500

Slovenská republika

KRKA Slovensko, s.r.o.

Tel: + 421 (0) 2 571 04 501

Italia

KRKA Farmaceutici Milano S.r.l.

Tel: + 39 02 3300 8841

Suomi/Finland

KRKA Finland Oy

Puh/Tel: + 358 20 754 5330

Κúπρος

KI.PA. (PHARMACAL) LIMITED

Τηλ: + 357 24 651 882

Sverige

KRKA Sverige AB

Tel: + 46 (0)8 643 67 66 (SE)

Latvija

KRKA Latvija SIA

Tel: + 371 6 733 86 10

United Kingdom (Northern Ireland)

KRKA Pharma Dublin, Ltd.

Tel: + 353 1 413 3710

Date of Last Revision of this Leaflet:

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2025 Oladoctor. All rights reserved.
VisaMastercardStripe